Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

CVRx, Inc. CVRX NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
49/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.50
+53.7%

Il y a eu 50 transactions d'initiés récentes enregistrées pour CVRx, Inc. (CVRX), dont 30 achats et 14 ventes. Le total des achats d'initiés s'élève à $7.54M et le total des ventes d'initiés à $1.01M.

Les initiés notables ayant une activité récente comprennent Hykes Kevin, Oasheim Jared, Verrastro Paul. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CVRX

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-02 Hykes Kevin Pres & CEO Vente Informative 7,763 $7.90 $61.35K 284,237
2026-03-02 Oasheim Jared Chief Financial Officer Vente Informative 1,744 $7.90 $13.78K 96,703
2026-03-02 Verrastro Paul Chief Mktg & Strat Officer Vente Informative 1,284 $7.90 $10.15K 60,551
2026-03-02 John Robert Allen Chief Revenue Officer Vente Informative 3,964 $7.90 $31.33K 86,036
2026-03-02 Morrison Gregory Officer Inconnu - - - -
2026-03-02 Morrison Gregory Chief Human Resources Officer Attribution de RSU 34,000 - - 34,000
2026-03-02 Adamson Philip B. Chief Medical Officer Vente Informative 1,262 $7.90 $9.97K 61,578
2026-02-27 Hykes Kevin Pres & CEO Attribution de RSU 238,000 $8.16 $1.94M 238,000
2026-02-27 Binkowski Brent Chief Operating Officer Attribution de RSU 23,000 $8.16 $187.68K 23,000
2026-02-27 Oasheim Jared Chief Financial Officer Attribution de RSU 91,000 $8.16 $742.56K 91,000
2026-02-27 Verrastro Paul Chief Mktg & Strat Officer Attribution de RSU 45,000 - - 61,835
2026-02-27 John Robert Allen Chief Revenue Officer Attribution de RSU 52,000 $8.16 $424.32K 52,000
2026-02-27 Adamson Philip B. Chief Medical Officer Attribution de RSU 62,000 $8.16 $505.92K 62,000
2026-02-20 Jain Mudit K. Director Achat Informatif 46,800 $6.36 $297.59K 980,183
2026-02-18 Jain Mudit K. Director Achat Informatif 600 $4.64 $2.79K 5,650
2025-11-26 Johnson & Johnson 10 Percent Owner Vente Informative 6,337 $10.03 $63.56K 4,024,861
2025-11-26 Johnson & Johnson 10 Percent Owner Vente Informative 6,337 $10.03 $63.56K 4,040,861
2025-11-25 Johnson & Johnson 10 Percent Owner Vente Informative 16,000 $10.03 $160.48K 4,031,198
2025-11-24 Johnson & Johnson 10 Percent Owner Vente Informative 2,200 $10.06 $22.13K 4,047,198
2025-11-21 Johnson & Johnson 10 Percent Owner Vente Informative 500 $10.00 $5K 4,049,398
2025-11-12 Johnson & Johnson 10 Percent Owner Vente Informative 1,000 $10.00 $10K 4,049,898
2025-11-07 Johnson & Johnson 10 Percent Owner Vente Informative 200 $10.00 $2K 4,050,898
2025-11-06 Johnson & Johnson 10 Percent Owner Vente Informative 52,332 $10.21 $534.31K 4,051,098
2025-08-11 Binkowski Brent Officer Inconnu - - - -
2025-08-11 Binkowski Brent Chief Operating Officer Attribution de RSU 16,600 - - 16,600
2025-06-03 Slattery Joseph P Director Attribution de RSU 19,554 $6.76 $132.19K 19,554
2025-06-03 Nielsen Kirk G. Director Attribution de RSU 19,554 $6.76 $132.19K 19,554
2025-06-03 Ballinger Kevin J. Director Attribution de RSU 19,554 $6.76 $132.19K 19,554
2025-06-03 Jain Mudit K. Director Attribution de RSU 19,554 $6.76 $132.19K 19,554
2025-06-03 Hill, Mitch C. Director Attribution de RSU 19,554 $6.76 $132.19K 19,554
2025-06-03 Shadan Martha Director Attribution de RSU 19,554 $6.76 $132.19K 19,554
2025-05-15 Nielsen Kirk G. Director Achat Informatif 10,966 $5.45 $59.8K 1,910,134
2025-05-14 Nielsen Kirk G. Director Achat Informatif 61,200 $5.23 $320.36K 1,899,168
2025-05-13 Jain Mudit K. Director Achat Informatif 150 $5.26 $789.00 5,050
2025-05-13 Nielsen Kirk G. Director Achat Informatif 101,413 $5.29 $536.31K 1,837,968
2025-05-12 Hykes Kevin Pres & CEO Achat Informatif 5,000 $4.84 $24.2K 133,000
2025-05-12 Jain Mudit K. Director Achat Informatif 1,500 $4.66 $6.99K 4,900
2025-05-12 Nielsen Kirk G. Director Achat Informatif 25,200 $4.79 $120.67K 1,736,555
2025-02-28 Hykes Kevin Pres & CEO Attribution de RSU 98,000 - - 128,000
2025-02-28 Oasheim Jared Chief Financial Officer Attribution de RSU 33,000 $12.96 $427.68K 33,000
2025-02-28 Verrastro Paul Chief Mktg & Strat Officer Attribution de RSU 16,000 - - 16,835
2025-02-28 John Robert Allen Chief Revenue Officer Attribution de RSU 38,000 $12.96 $492.48K 38,000
2025-02-28 Adamson Philip B. Chief Medical Officer Attribution de RSU 20,000 - - 20,000
2025-02-04 Adamson Philip B. Chief Medical Officer Inconnu 190,208 $7.82 $1.49M -
2024-11-21 Verrastro Paul Chief Mktg & Strat Officer Don (Donné) 1,040 - - 835
2024-11-19 Verrastro Paul Chief Mktg & Strat Officer Vente Informative 1,430 $13.58 $19.42K 1,875
2024-09-03 Ballinger Kevin J. Officer Inconnu - - - -
2024-09-03 Ballinger Kevin J. Director Attribution de RSU 36,136 $9.05 $327.03K 36,136
2024-09-03 Hill, Mitch C. Officer Inconnu - - - -
2024-09-03 Hill, Mitch C. Director Attribution de RSU 36,136 $9.05 $327.03K 36,136
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message